Differential effects of subchronic Phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests

Behavioural Brain Research

Volumn 243, Issue 1, 2013, Pages 61-65

  Enkel, Thomas ^a   Thomas, Mara ^a   Bartsch, Dusan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anxiety; Light enhanced startle; Phencyclidine; Rat; Schizophrenia

Indexed keywords

PHENCYCLIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL TEST; EXPLORATORY RESEARCH; LATENT PERIOD; LIGHT DARK CYCLE; LIGHT DARK EXPLORATION TEST; LIGHT ENHANCED STARTLE TEST; LOCOMOTION; MALE; MOTIVATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; LIGHT; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION;

EID: 84872513660     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.12.060     Document Type: Article

References (28)

1. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behavioural Brain Research 1996, 74:45-55.
2. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17:92-99.
3. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 1998, 19:105-113.
4. Jentsch J.D., Dazzi L., Chhatwal J.P., Verrico C.D., Roth R.H. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neuroscience Letters 1998, 258:175-178.
5. Arvanov V.L., Wang R.Y. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-d-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. Journal of Pharmacology and Experimental Therapeutics 1999, 289:1000-1006.
6. Xiao X., Dawson N., Macintyre L., Morris B.J., Pratt J.A., Watson D.G., et al. Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the generalized singular value decomposition. BMC Systems Biology 2011, 5:72-92.
7. Rodefer J.S., Murphy E.R., Baxter M.G. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. European Journal of Neuroscience 2005, 21:1070-1076.
8. Dunn M.J., Killcross S. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance. Behavioural Brain Research 2006, 175:271-277.
9. Grayson B., Idris N.F., Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behavioural Brain Research 2007, 184:31-38.
10. Eysenck M.W., Derakshan N., Santos R., Calvo M.G. Anxiety and cognitive performance: attentional control theory. Emotion 2007, 7:336-353.
11. Visu-Petra L., Miclea M., Visu-Petra G. Individual differences in anxiety and executive functioning: a multidimensional view. International Journal of Psychology 2012, 10.1080/00207594.2012.656132.
12. Audet M.C., Goulet S., Dore F.Y. Enhanced anxiety follows withdrawal from subchronic exposure to phencyclidine in rats. Behavioural Brain Research 2007, 176:358-361.
13. McLean S.L., Woolley M.L., Neill J.C. Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field. Journal of Psychopharmacology 2010, 24:787-790.
14. Turgeon S.M., Case L.C. The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat. Brain Research 2001, 888:302-305.
15. Grillon C., Pellowski M., Merikangas K.R., Davis M. Darkness facilitates the acoustic startle reflex in humans. Biological Psychiatry 1997, 42:453-460.
16. Grillon C., Baas J. A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clinical Neurophysiology 2003, 114:1557-1579.
17. Walker D.L., Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology 2002, 159:304-310.
18. Bailey K.R., Crawley JN Anxiety-related behaviors in mice. Methods of Behavior Analysis in Neuroscience 2009, CRC Press, Boca Raton, Available from:. http://www.ncbi.nlm.nih.gov/books/NBK5221/, 2nd edition. J.J. Buccafusco (Ed.).
19. Turgeon S.M., Kim D., Pritchard M., Salgado S., Thaler A. The effects of phencyclidine (PCP) on anxiety-like behavior in the elevated plus maze and the light-dark exploration test are age dependent, sexually dimorphic, and task dependent. Pharmacology Biochemistry and Behavior 2011, 100:191-198.
20. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology Biochemistry and Behavior 1996, 54:21-30.
21. Schrijver N.C., Bahr N.I., Weiss I.C., Wurbel H. Dissociable effects of isolation rearing and environmental enrichment on exploration, spatial learning and HPA activity in adult rats. Pharmacology Biochemistry and Behavior 2002, 73:209-224.
22. Heiderstadt K.M., McLaughlin R.M., Wright D.C., Walker S.E., Gomez-Sanchez C.E. The effect of chronic food and water restriction on open-field behaviour and serum corticosterone levels in rats. Laboratory Animals 2000, 34:20-28.
23. Martin B., Pearson M., Kebejian L., Golden E., Keselman A., Bender M., et al. Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology 2007, 148:4318-4333.
24. Martin B., Ji S., Maudsley S., Mattson M.P. Control laboratory rodents are metabolically morbid: why it matters. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:6127-6133.
25. Tenn C.C., Kapur S., Fletcher P.J. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology 2005, 180:366-376.
26. Jentsch J.D., Tran A., Taylor J.R., Roth R.H. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology 1998, 138:89-95.
27. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:13508-13514.
28. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience 2009, 10:423-433.